Johnson & Johnson (JNJ)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$0.52 (-0.35%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Johnson & Johnson (JNJ)
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.

Key Insights

Critical company metrics and information
  • Share Price

    $149.31
  • Market Cap

    $359.48 Billion
  • Total Outstanding Shares

    2.41 Billion Shares
  • Total Employees

    134,400
  • Dividend

    $1.24 Per Share Quarterly
  • IPO Date

    September 25, 1944
  • SIC Description

    Pharmaceutical Preparations
  • Homepage

    https://www.jnj.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

September 30, 2023 to September 29, 2024
MetricValue
Net Cash Flow, Continuing$218.00 Million
Net Cash Flow From Financing Activities, Continuing$-6.45 Billion
Net Cash Flow From Operating Activities$25.15 Billion
Net Cash Flow From Operating Activities, Continuing$25.15 Billion
Net Cash Flow From Investing Activities, Continuing$-18.48 Billion
Net Cash Flow From Investing Activities$-18.48 Billion
Exchange Gains/Losses$34.00 Million
Net Cash Flow From Financing Activities$-6.45 Billion
Net Cash Flow$252.00 Million

Income Statement

September 30, 2023 to September 29, 2024
MetricValue
Benefits Costs and Expenses$70.07 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Basic Earnings Per Share$6.10
Net Income/Loss Attributable To Parent$14.68 Billion
Revenues$87.70 Billion
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Income Tax Expense/Benefit$2.86 Billion
Costs And Expenses$70.07 Billion
Diluted Earnings Per Share$6.05
Cost Of Revenue$27.14 Billion
Income/Loss From Discontinued Operations Net Of Tax$-83.00 Million
Preferred Stock Dividends And Other Adjustments$0.00
Operating Income/Loss$17.63 Billion
Net Income/Loss Available To Common Stockholders, Basic$14.68 Billion
Income/Loss From Discontinued Operations Net Of Tax Gain/Loss On Disposal$0.00
Common Stock Dividends$4.86
Gross Profit$60.55 Billion
Diluted Average Shares$2.39 Billion
Operating Expenses$42.93 Billion
Selling, General, and Administrative Expenses$22.23 Billion
Net Income/Loss$14.68 Billion
Income/Loss From Continuing Operations Before Tax$17.63 Billion
Basic Average Shares$2.37 Billion
Income/Loss From Continuing Operations After Tax$14.77 Billion
Other Operating Expenses$20.22 Billion
Income Tax Expense/Benefit, Deferred$-4.58 Billion

Balance Sheet

September 30, 2023 to September 29, 2024
MetricValue
Intangible Assets$39.49 Billion
Liabilities And Equity$178.29 Billion
Current Liabilities$51.76 Billion
Equity Attributable To Noncontrolling Interest$0.00
Noncurrent Assets$125.04 Billion
Accounts Payable$8.95 Billion
Wages$3.62 Billion
Cash$20.30 Billion
Equity$70.16 Billion
Current Assets$53.25 Billion
Noncurrent Liabilities$56.37 Billion
Other Non-current Assets$65.07 Billion
Liabilities$108.13 Billion
Assets$178.29 Billion
Other Current Assets$20.35 Billion
Other Current Liabilities$39.19 Billion
Inventory$12.60 Billion
Fixed Assets$20.48 Billion
Equity Attributable To Parent$70.16 Billion

Historical Dividends

Current dividend: $1.24 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Oct 15, 2024Dec 10, 2024Nov 26, 2024$1.24Quarterly
Jul 17, 2024Sep 10, 2024Aug 27, 2024$1.24Quarterly
Apr 16, 2024Jun 4, 2024May 21, 2024$1.24Quarterly
Jan 2, 2024Mar 5, 2024Feb 20, 2024$1.19Quarterly
Oct 19, 2023Dec 5, 2023Nov 21, 2023$1.19Quarterly
Jul 20, 2023Sep 7, 2023Aug 28, 2023$1.19Quarterly
Apr 18, 2023Jun 6, 2023May 23, 2023$1.19Quarterly
Jan 3, 2023Mar 7, 2023Feb 21, 2023$1.13Quarterly
Oct 19, 2022Dec 6, 2022Nov 22, 2022$1.13Quarterly
Jul 18, 2022Sep 6, 2022Aug 23, 2022$1.13Quarterly
Apr 19, 2022Jun 7, 2022May 24, 2022$1.13Quarterly
Jan 4, 2022Mar 8, 2022Feb 22, 2022$1.06Quarterly
Oct 21, 2021Dec 7, 2021Nov 23, 2021$1.06Quarterly
Jul 19, 2021Sep 7, 2021Aug 24, 2021$1.06Quarterly
Apr 20, 2021Jun 8, 2021May 25, 2021$1.06Quarterly
Jan 4, 2021Mar 9, 2021Feb 23, 2021$1.01Quarterly
Oct 22, 2020Dec 8, 2020Nov 24, 2020$1.01Quarterly
Jul 20, 2020Sep 8, 2020Aug 25, 2020$1.01Quarterly
Apr 14, 2020Jun 9, 2020May 26, 2020$1.01Quarterly
Jan 2, 2020Mar 10, 2020Feb 25, 2020$0.95Quarterly
Oct 17, 2019Dec 10, 2019Nov 26, 2019$0.95Quarterly
Jul 15, 2019Sep 10, 2019Aug 27, 2019$0.95Quarterly
Apr 25, 2019Jun 11, 2019May 28, 2019$0.95Quarterly
Jan 2, 2019Mar 12, 2019Feb 26, 2019$0.9Quarterly
Oct 18, 2018Dec 11, 2018Nov 27, 2018$0.9Quarterly
Jul 16, 2018Sep 11, 2018Aug 28, 2018$0.9Quarterly
Apr 26, 2018Jun 12, 2018May 29, 2018$0.9Quarterly
Jan 2, 2018Mar 13, 2018Feb 27, 2018$0.84Quarterly
Oct 19, 2017Dec 12, 2017Nov 28, 2017$0.84Quarterly
Jul 17, 2017Sep 12, 2017Aug 29, 2017$0.84Quarterly
Apr 27, 2017Jun 13, 2017May 30, 2017$0.84Quarterly
Jan 3, 2017Mar 14, 2017Feb 28, 2017$0.8Quarterly
Oct 20, 2016Dec 6, 2016Nov 22, 2016$0.8Quarterly
Jul 18, 2016Sep 6, 2016Aug 23, 2016$0.8Quarterly
Apr 28, 2016Jun 7, 2016May 24, 2016$0.8Quarterly
Jan 4, 2016Mar 8, 2016Feb 23, 2016$0.75Quarterly
Oct 22, 2015Dec 8, 2015Nov 24, 2015$0.75Quarterly
Apr 23, 2015Jun 9, 2015May 26, 2015$0.75Quarterly
Jan 5, 2015Mar 10, 2015Feb 24, 2015$0.7Quarterly
Oct 16, 2014Dec 9, 2014Nov 25, 2014$0.7Quarterly
Jul 21, 2014Sep 9, 2014Aug 26, 2014$0.7Quarterly
Apr 24, 2014Jun 10, 2014May 27, 2014$0.7Quarterly
Jan 2, 2014Mar 11, 2014Feb 25, 2014$0.66Quarterly
Oct 17, 2013Dec 10, 2013Nov 26, 2013$0.66Quarterly
Jul 15, 2013Sep 10, 2013Aug 27, 2013$0.66Quarterly
Apr 25, 2013Jun 11, 2013May 28, 2013$0.66Quarterly
Jan 2, 2013Mar 12, 2013Feb 26, 2013$0.61Quarterly
Oct 17, 2012Dec 11, 2012Nov 27, 2012$0.61Quarterly

Related Companies

View additional S&P 500 companies similar to Johnson & Johnson (JNJ)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.